Discover our initiatives in various therapeutic areas
Deroxi liposomal® is indicated for the treatment of:
cancer of the breast in patients at risk for heart problems.
Cancer of the ovary.
In combination with another medicine, bortezomib, to treat
multiple myeloma (a cancer of the blood) in patients who have received at least 1 prior
therapy.
Produce an improvement in Kaposi’s sarcoma.
Strength:
2 mg/ml
Dosage Form:
Concentrate for solution for infusion
Active ingredient:
Doxorubicin Hydrochloride